These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12801889)

  • 1. Functional role of the NPxxY motif in internalization of the type 2 vasopressin receptor in LLC-PK1 cells.
    Bouley R; Sun TX; Chenard M; McLaughlin M; McKee M; Lin HY; Brown D; Ausiello DA
    Am J Physiol Cell Physiol; 2003 Oct; 285(4):C750-62. PubMed ID: 12801889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterologous downregulation of vasopressin type 2 receptor is induced by transferrin.
    Bouley R; Nunes P; Andriopoulos B; McLaughlin M; Webber MJ; Lin HY; Babitt JL; Gardella TJ; Ausiello DA; Brown D
    Am J Physiol Renal Physiol; 2013 Mar; 304(5):F553-64. PubMed ID: 23235478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aquaporin 2 (AQP2) and vasopressin type 2 receptor (V2R) endocytosis in kidney epithelial cells: AQP2 is located in 'endocytosis-resistant' membrane domains after vasopressin treatment.
    Bouley R; Hawthorn G; Russo LM; Lin HY; Ausiello DA; Brown D
    Biol Cell; 2006 Apr; 98(4):215-32. PubMed ID: 16563128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visualizing microtubule-dependent vasopressin type 2 receptor trafficking using a new high-affinity fluorescent vasopressin ligand.
    Chen S; Webber MJ; Vilardaga JP; Khatri A; Brown D; Ausiello DA; Lin HY; Bouley R
    Endocrinology; 2011 Oct; 152(10):3893-904. PubMed ID: 21828182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopressin receptor-mediated functional signaling pathway in primary cilia of renal epithelial cells.
    Raychowdhury MK; Ramos AJ; Zhang P; McLaughin M; Dai XQ; Chen XZ; Montalbetti N; Del Rocío Cantero M; Ausiello DA; Cantiello HF
    Am J Physiol Renal Physiol; 2009 Jan; 296(1):F87-97. PubMed ID: 18945824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low pH stimulates vasopressin V2 receptor promoter activity and enhances downregulation induced by V1a receptor stimulation.
    Memetimin H; Izumi Y; Nakayama Y; Kohda Y; Inoue H; Nonoguchi H; Tomita K
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F620-8. PubMed ID: 19587140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calmodulin interacts with the V2 vasopressin receptor: elimination of binding to the C terminus also eliminates arginine vasopressin-stimulated elevation of intracellular calcium.
    Nickols HH; Shah VN; Chazin WJ; Limbird LE
    J Biol Chem; 2004 Nov; 279(45):46969-80. PubMed ID: 15319442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of V2R transcription by hypertonicity and V1aR-V2R signal interaction.
    Izumi Y; Nakayama Y; Memetimin H; Inoue T; Kohda Y; Nonoguchi H; Tomita K
    Am J Physiol Renal Physiol; 2008 Oct; 295(4):F1170-6. PubMed ID: 18701631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenoviral gene transfer of the human V2 vasopressin receptor improves contractile force of rat cardiomyocytes.
    Laugwitz KL; Ungerer M; Schöneberg T; Weig HJ; Kronsbein K; Moretti A; Hoffmann K; Seyfarth M; Schultz G; Schömig A
    Circulation; 1999 Feb; 99(7):925-33. PubMed ID: 10027817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of the vasopressin type 2 receptor after vasopressin-induced internalization: involvement of a lysosomal degradation pathway.
    Bouley R; Lin HY; Raychowdhury MK; Marshansky V; Brown D; Ausiello DA
    Am J Physiol Cell Physiol; 2005 Jun; 288(6):C1390-401. PubMed ID: 15677378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VRQ397 (CRAVKY): a novel noncompetitive V2 receptor antagonist.
    Rihakova L; Quiniou C; Hamdan FF; Kaul R; Brault S; Hou X; Lahaie I; Sapieha P; Hamel D; Shao Z; Gobeil F; Hardy P; Joyal JS; Nedev H; Duhamel F; Beauregard K; Heveker N; Saragovi HU; Guillon G; Bouvier M; Lubell WD; Chemtob S
    Am J Physiol Regul Integr Comp Physiol; 2009 Oct; 297(4):R1009-18. PubMed ID: 19641130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the vasopressin V2 receptor by vasopressin in polarized renal collecting duct cells.
    Robben JH; Knoers NV; Deen PM
    Mol Biol Cell; 2004 Dec; 15(12):5693-9. PubMed ID: 15469988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An X-linked NDI mutation reveals a requirement for cell surface V2R expression.
    Sadeghi HM; Innamorati G; Birnbaumer M
    Mol Endocrinol; 1997 Jun; 11(6):706-13. PubMed ID: 9171234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monensin-resistant LLC-PK1 cell mutants are affected in recycling of the adenylate cyclase-stimulating vasopressin V2-receptor.
    Jans DA; Jans P; Luzius H; Fahrenholz F
    Mol Cell Endocrinol; 1991 Oct; 81(1-3):165-74. PubMed ID: 1797584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An extracellular congenital nephrogenic diabetes insipidus mutation of the vasopressin receptor reduces cell surface expression, affinity for ligand, and coupling to the Gs/adenylyl cyclase system.
    Birnbaumer M; Gilbert S; Rosenthal W
    Mol Endocrinol; 1994 Jul; 8(7):886-94. PubMed ID: 7984150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of vasopressin type 2 receptor substitutions (R137H/C/L) leading to nephrogenic diabetes insipidus and nephrogenic syndrome of inappropriate antidiuresis: implications for treatments.
    Rochdi MD; Vargas GA; Carpentier E; Oligny-Longpré G; Chen S; Kovoor A; Gitelman SE; Rosenthal SM; von Zastrow M; Bouvier M
    Mol Pharmacol; 2010 May; 77(5):836-45. PubMed ID: 20159941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus in a polarized cell model.
    Robben JH; Knoers NV; Deen PM
    Am J Physiol Renal Physiol; 2005 Aug; 289(2):F265-72. PubMed ID: 16006591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the renal medullary pH and ionic environment on vasopressin binding and signaling.
    Zalyapin EA; Bouley R; Hasler U; Vilardaga JP; Lin HY; Brown D; Ausiello DA
    Kidney Int; 2008 Dec; 74(12):1557-67. PubMed ID: 18813286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appropriate polarization following pharmacological rescue of V2 vasopressin receptors encoded by X-linked nephrogenic diabetes insipidus alleles involves a conformation of the receptor that also attains mature glycosylation.
    Tan CM; Nickols HH; Limbird LE
    J Biol Chem; 2003 Sep; 278(37):35678-86. PubMed ID: 12824183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin receptor-mediated endocytosis: current view.
    Lutz W; Salisbury JL; Kumar R
    Am J Physiol; 1991 Jul; 261(1 Pt 2):F1-13. PubMed ID: 1650143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.